Table 1 Preoperative clinical characteristics.
Parameters | Control group (n = 25) | Dexmedetomidine group (n = 26) | P value |
|---|---|---|---|
Age (years) | 61 ± 17 | 62 ± 17 | 0.838 |
Sex, male/female | 14 /11 | 14/12 | 0.877 |
Height (cm) | 165.7 ± 10.4 | 165.9 ± 10.4 | 0.937 |
Weight (kg) | 64.5 ± 14.3 | 69.7 ± 15.2 | 0.215 |
Hypertension | 17 (68.0) | 18 (69.2) | 0.925 |
Diabetes mellitus | 3 (12.0) | 3 (11.5) | > 0.999 |
Chronic kidney disease | 2 (8.0) | 2 (7.7) | > 0.999 |
Cerebrovascular accident | 2 (8.0) | 2 (7.7) | > 0.999 |
Coronary artery disease | 4 (16.0) | 3 (11.5) | 0.703 |
Medication | |||
β-Blockers | 7 (28.0) | 5 (19.2) | 0.461 |
Calcium channel blockers | 11 (44.0) | 8 (30.8) | 0.329 |
RAS blockers | 9 (36.0) | 12 (46.2) | 0.461 |
Diuretics | 4 (16.0) | 2 (7.7) | 0.419 |
Preoperative pulmonary function*** | |||
FVC | 96.1 ± 25.5 | 93.4 ± 16.2 | 0.814 |
FEV1 | 103.6 ± 24.3 | 96.4 ± 14.1 | 0.504 |
FEV1/FVC | 73.3 ± 3.5 | 70.1 ± 8.3 | 0.382 |
DLCO | 90.9 ± 17.0 | 90.83 ± 10.3 | 0.998 |
Euroscore | 6 ± 5 | 7 ± 7 | 0.880 |
Preoperative LVEF (%) | 62 ± 9 | 64 ± 6 | 0.538 |
